SUN PHARMACEUTICAL INDUSTRIES
Back to Income Statement
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹9,576 Cr | ₹8,474 Cr | ₹3,273 Cr | ₹2,904 Cr | ₹3,765 Cr |
What is the latest Consolidated Net Profit of SUN PHARMACEUTICAL INDUSTRIES ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹9,576 Cr |
| Mar2024 | ₹8,474 Cr |
| Mar2023 | ₹3,273 Cr |
| Mar2022 | ₹2,904 Cr |
| Mar2021 | ₹3,765 Cr |
How is Consolidated Net Profit of SUN PHARMACEUTICAL INDUSTRIES Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹9,576 Cr | 13.01 | |
| Mar2024 | ₹8,474 Cr | 158.91 | |
| Mar2023 | ₹3,273 Cr | 12.70 | |
| Mar2022 | ₹2,904 Cr | -22.87 | |
| Mar2021 | ₹3,765 Cr | - | |
Compare Consolidated Net Profit of peers of SUN PHARMACEUTICAL INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMACEUTICAL INDUSTRIES | ₹431,994.0 Cr | -0.4% | 5.3% | 13.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,076.0 Cr | -4.3% | -6.3% | 12.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,510.0 Cr | 0.4% | 8.2% | 44.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,921.0 Cr | 0.5% | 1.8% | 16.4% | Stock Analytics | |
| CIPLA | ₹106,150.0 Cr | -0.8% | -2.6% | -9.2% | Stock Analytics | |
| MANKIND PHARMA | ₹88,243.3 Cr | -1.1% | 2.4% | -4.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMACEUTICAL INDUSTRIES | -0.4% |
5.3% |
13.4% |
| SENSEX | -5.5% |
-11.5% |
0.3% |
You may also like the below Video Courses